Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.
about
Arsenic exposure and hepatitis Evirus infection during pregnancyArsenic in Drinking Water and Mortality for Cancer and Chronic Diseases in Central Italy, 1990-2010Arsenic Exposure and Predicted 10-Year Atherosclerotic Cardiovascular Risk Using the Pooled Cohort Equations in U.S. Hypertensive AdultsEnvironmental Exposures and Cardiovascular Disease: A Challenge for Health and Development in Low- and Middle-Income CountriesCreatinine, arsenic metabolism, and renal function in an arsenic-exposed population in BangladeshInteraction between arsenic exposure from drinking water and genetic polymorphisms on cardiovascular disease in Bangladesh: a prospective case-cohort studyRisk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based studyGene-arsenic interaction in longitudinal changes of blood pressure: Findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in BangladeshPrenatal arsenic exposure alters the programming of the glucocorticoid signaling system during embryonic development.Linkage Analysis of Urine Arsenic Species Patterns in the Strong Heart Family StudyThe Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence.Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study.Chronic arsenic exposure and risk of carotid artery disease: The Strong Heart Study.Arsenic metabolism and one-carbon metabolism at low-moderate arsenic exposure: Evidence from the Strong Heart Study.Maternal and infant inflammatory markers in relation to prenatal arsenic exposure in a U.S. pregnancy cohort.Urine Arsenic and Arsenic Metabolites in U.S. Adults and Biomarkers of Inflammation, Oxidative Stress, and Endothelial Dysfunction: A Cross-Sectional Study.Arsenic exposure assists ccm3 genetic polymorphism in elevating blood pressure.Arsenic association with circulating oxidized low-density lipoprotein in a Native American community.
P2860
Q23911146-050177A9-456A-49D3-A0D3-B7973C26DABFQ28389035-CA12797E-047B-4FA4-8B3D-2634E5F1B9BDQ28395321-3D855B9F-CC68-408B-BBC6-E7E1A348A7C9Q28395373-79E15B92-E978-450C-A095-468E6BAB9E9AQ34599799-E3DF23DA-BE11-4E55-8482-C955F8871520Q35574651-0D8E90BA-E35E-4C1F-83E5-C3DD1F0FFF4EQ35952226-1C8A1E8C-9A2C-43AC-95A2-2CE2F8F9FC06Q36165005-5EBF6CC7-A8DA-46BC-B64A-FFA7F7407FAAQ36354483-C7A1B5FD-7AF5-4E84-A87A-865D56E28BB6Q36515907-0846AF19-1BD6-4427-9E25-56D8808C7202Q38400126-08303C52-BD06-4203-92E9-BCD20D7B2D95Q38400520-43A474D3-96DE-41F2-8B3A-5400FCD946CCQ38402420-6CE0B057-5C5E-4A35-996E-39A70E938381Q38799609-EFC063D5-D275-4C92-A4A1-C8294BA3335DQ40242144-35E7D5CD-7717-4090-A9F7-1972F1D91913Q49649299-E132D27C-61FB-46E6-B456-641855268F1EQ49664601-E91A33D0-73F3-4DEE-9D71-6A0AA0F692DAQ52593963-E570300B-FD3E-4C1E-B6FF-B6EF0E7863BB
P2860
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.
@ast
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.
@en
type
label
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.
@ast
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.
@en
prefLabel
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.
@ast
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.
@en
P2860
P1476
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases
@en
P2093
Peter Molinaro
P2860
P2888
P304
P356
10.1007/S40572-014-0011-2
P50
P577
2014-06-01T00:00:00Z
P5875
P6179
1035910258